Advisor Shares Investments LLC Cybin Inc. Transaction History

Advisor Shares Investments LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$0.26 - $0.46 $57,304 - $101,385	220,403 Added 13.4%	1,865,217 $503,000
Q1 2024 May 14, 2024	SELL	$0.3 - $0.46 $64,310 - $98,608	-214,367 Reduced 11.53%	1,644,814 $674,000
Q4 2023 Feb 13, 2024	SELL	$0.38 - $0.65 $34,679 - $59,319	-91,261 Reduced 4.68%	1,859,181 $762,000
Q3 2023 Nov 06, 2023	SELL	$0.29 - $0.63 $61,536 - $133,682	-212,194 Reduced 9.81%	1,950,442 $1.03 Million
Q2 2023 Aug 09, 2023	SELL	$0.23 - $0.39 $27,211 - $46,140	-118,309 Reduced 5.19%	2,162,636 $821,000
Q1 2023 May 09, 2023	BUY	$0.3 - $0.56 $180,784 - $337,463	602,614 Added 35.91%	2,280,945 $866,000
Q4 2022 Feb 14, 2023	BUY	$0.26 - $0.64 $62,113 - $152,894	238,898 Added 16.6%	1,678,331 $503,000
Q3 2022 Nov 14, 2022	BUY	$0.48 - $1.11 $188,017 - $434,790	391,703 Added 37.39%	1,439,433 $697,000
Q2 2022 Aug 08, 2022	BUY	$0.41 - $0.88 $57,822 - $124,107	141,031 Added 15.55%	1,047,730 $587,000
Q1 2022 May 09, 2022	BUY	$0.74 - $1.22 $239,401 - $394,688	323,515 Added 55.47%	906,699 $741,000
Q4 2021 Jan 31, 2022	BUY	$1.13 - $2.31 $554,871 - $1.13 Million	491,037 Added 532.88%	583,184 $700,000
Q3 2021 Nov 04, 2021	BUY	$1.83 - $3.18 $168,629 - $293,027	92,147 New	92,147 $202,000

185K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $2.07B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Advisor Shares Investments LLC with notifications on news.